As neurological disorders account for nearly 10% of India’s overall disease burden and remain among the top causes of disability globally, Gurugram-based Medanta – The Medicity is deepening its footprint in advanced neuro care through its specialised Deep Brain Stimulation (DBS) programme, popularly known as ‘Brain Pacemaker’ surgery. Named Best Private Hospital in India by Newsweek for six consecutive years, Medanta has positioned itself as an internationally recognised destination for DBS therapy. The procedure offers relief to patients suffering from advanced-stage Parkinson’s disease, dystonia, refractory epilepsy (adult onset), essential tremor and advanced obsessive-compulsive disorder (OCD), especially when conventional medicines fail to control symptoms.
The programme is led by Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram, who has performed over 300 DBS surgeries in the past 15 years with consistently high success rates.
DBS involves implanting electrodes in specific brain regions to regulate abnormal signals and restore motor function, improving patients’ quality of life. Medanta’s offering integrates advanced imaging for precise targeting, directional leads for multi-dimensional neuromodulation, real-time brain-sensing biomarker feedback, AI-guided precision targeting and remote programming capabilities, reinforcing its investment in technology-driven, personalised neurological care across North and East India.
